Promoter of the canine tracheobronchial mucin gene Conference Paper


Authors: Verma, M.; Murthy, V. V. S.; Mathew, S.; Banerji, D.; Kurl, R. N.; Olnes, M. J.; Yankaskas, J. R.; Blass, C.; Davidson, E. A.
Title: Promoter of the canine tracheobronchial mucin gene
Conference Title: Royal Society of Chemistry Carbohydrate Group and Biochemical Society Glycobiology Group Joint Spring Meeting
Abstract: The mucin gene is up-regulated in diseases such as cystic fibrosis (CF) and asthma. To understand the mechanisms involved in transcriptional regulation of mucin gene expression we have characterized the region of the mucin gene up-stream of the transcriptional start site and analysed the cis-acting elements required for mucin promoter activity. We isolated clones from a dog genomic library containing the promoter region for the tracheobronchial mucin gene (TBM). The authenticity of the promoter was tested by nucleotide sequencing, primer extension analysis, electrophoretic mobility shift assay (EMSA) and reporter gene expression analysis. The canine TBM promoter is different from housekeeping gene promoters (as it is not rich in GC content and contains TATA- and CAAT-like sequences) and different from that of regulatory genes (because it contains many TATA- and CAAT-like sequences and multiple transcriptional initiation sites). Reporter gene analysis using canine TBM promoter-chloramphenicol acetyltransferase (CAT) fusion plasmids established the regions responsible for promoter activity and verified the positions of the major mucin transcriptional initiation sites. Reporter gene analysis also established that a region of the canine TBM promoter and first exon containing all of the transcriptional initiation sites is more active in mucin expressing cells (e.g. CT1 cells-immortalized canine tracheal epithelial cells, human CFT1 cells-immortalized tracheal epithelial cells from a CF subject, or HBE1 cells-immortalized tracheal epithelial cells from non-CF subject) than in mucin non-expressing cells (COS7, 3T3), suggesting cell specificity. The promoter region contained cAMP response element (CRE) sequences, and the TBM gene transcription was enhanced when cAMP analogs were added to transfected cells. EMSA indicated the presence of at least DNA binding proteins in CT1 cells. This is the first report describing the characterization of a TBM gene promoter. The information obtained in the present studies will be valuable in understanding mucin gene regulation in normal and pathological conditions.
Keywords: promoter region; sequence analysis; dna-binding proteins; nonhuman; conference paper; genetic analysis; animals; animal tissue; genetic transcription; animalia; transcription factors; nuclear proteins; gene expression regulation; molecular cloning; cloning, molecular; molecular sequence data; dog; dogs; transcription; epithelial cells; base sequence; binding sites; genes, reporter; antibodies; nucleic acid hybridization; nucleic acid conformation; bronchi; glycoprotein; electrophoresis, polyacrylamide gel; trachea; cyclic amp response element-binding protein; mucin; mucins; promoter; canis familiaris; promoter regions (genetics); papillomavirus; immortalization; felis catus; priority journal; cyclic amp response element; cystuc fubrisus; papilloma virus vectors
Journal Title Glycoconjugate Journal
Volume: 13
Issue: 5
Conference Dates: 1996 Mar 25-28
Conference Location: St Andrews, Scotland
ISBN: 0282-0080
Publisher: Springer New York LLC  
Date Published: 1996-10-01
Start Page: 797
End Page: 807
Language: English
DOI: 10.1007/bf00702344
PUBMED: 8910007
PROVIDER: scopus
DOI/URL:
Notes: Conference Paper -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vundavalli V. V. S. Murty
    53 Murty
  2. Susan Mathew
    26 Mathew